A phase II study of pembrolizumab in EGFR-mutant, PD-L1+, tyrosine kinase inhibitor (TKI) naïve patients with advanced NSCLC von Lisberg, Aaron Elliott, Cummings, Amy Lauren, Goldman, Jonathan Wade, Bornazyan, Krikor, Reese, Nicholas Dean, Wang, Tina, Coluzzi, Paul, Ledezma, Blanca A., Mendenhall, Melody A., Jones, Benjamin, Madrigal, John, Carroll, James M., Gukasyan, Jaklin, Williams, Tawny, Sauer, Lauren, Wells, Courtney L, Hardy, Ariana R, Linares, Paulina J, Adame, Carlos R., Garon, Edward B.

Volltext

Effects of FDA drug approvals on a thoracic oncology program’s clinical trial enrollment in 2015 von Li, Alice Huai-Yu, Goldman, Jonathan Wade, Spiegel, Marshall L., Adame, Carlos R., Wells, Courtney L., Lisberg, Aaron Elliott, Strunck, Jennifer L., Famenini, Sina, Carroll, James M., Tucker, D. Andrew, Hardy, Ariana R., Morris, Karolyn K., Linares, Paulina J., Sauer, Lauren, Wong, Deborah Jean Lee, Ledezma, Blanca A., Mendenhall, Melody A., Brennan, Meghan B., Abaya, Christina DiLauro, Garon, Edward B.

Volltext

Possible Zika Virus Infection Among Pregnant Women — United States and Territories, May 2016 von Simeone, Regina M., Shapiro-Mendoza, Carrie K., Meaney-Delman, Dana, Petersen, Emily E., Galang, Romeo R., Oduyebo, Titilope, Rivera-Garcia, Brenda, Valencia-Prado, Miguel, Newsome, Kimberly B., Pérez-Padilla, Janice, Williams, Tonya R., Biggerstaff, Matthew, Jamieson, Denise J., Honein, Margaret A.

Volltext